FASN and metabolic dysfunction-associated steatotic liver disease: The significant increase of insulin induced by the WD could lead to an upregulation of Fasn gene expression and thus, to the increase of hepatic lipid accumulation, while maintaining normal insulin levels does not promote the activation of de novo lipogenesis and triglyceride synthesis, protecting the liver from NAFLD development (45, 46).